VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $42,000 | -69.8% | 51,000 | -31.6% | 0.06% | -73.6% |
| Q2 2017 | $139,000 | +396.4% | 74,600 | +43.5% | 0.24% | +545.9% |
| Q1 2017 | $28,000 | -91.5% | 52,000 | -28.5% | 0.04% | -90.2% |
| Q4 2016 | $328,000 | +146.6% | 72,682 | -10.7% | 0.38% | +258.1% |
| Q3 2016 | $133,000 | -91.7% | 81,400 | -14.5% | 0.10% | -92.4% |
| Q2 2016 | $1,603,000 | -21.8% | 95,200 | -65.0% | 1.38% | -35.9% |
| Q1 2016 | $2,050,000 | +109.6% | 272,100 | +31.3% | 2.15% | +197.4% |
| Q4 2015 | $978,000 | – | 207,200 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |